Reference only. This page covers what the compound is, how it is presented and how it is handled. It does not give dosing protocols or administration schedules, and it is not medical advice.
What Cagrilintide is
Cagrilintide is an analogue of amylin, a hormone co-secreted with insulin from pancreatic beta cells. It is not an incretin and does not act at the GLP-1 receptor, which is why it appears in research alongside those compounds rather than as an alternative to them.
How the pen is supplied
Solution in a sealed 3 ml pen graduated in 300 dial units.
Pen specification
| Class | Long acting amylin analogue |
| Also known as | AM833 |
| Content | 15 mg |
| Fill volume | 3 ml |
| Dial graduation | 0.01 ml per unit |
| Total dial units | 300 |
| Per dial unit | 50 mcg |
| Cost per mg | £5.67 per mg |
Milligrams per dial unit and cost per milligram are calculated from the pen strength, its fill volume and the current live price. Every SerenQ pen is graduated at 0.01 ml per unit.
Verification
Independent HPLC per batch, identifier printed on the pen.
Stocked at The PED Shop
- SerenQ Cagrilintide 15mg Peptide Penout of stock£85
Availability checked 2026-09-04. The product page carries live stock.
Common questions
Is cagrilintide a GLP-1?
No. It is an amylin analogue, a different hormone acting through a different receptor family.